Posts filtered by tags: Hans Pennink[x]


 

Moderna CEO says data on the Covid-19 vaccine in young children likely won't be available until 2022

A nurse prepares a coronavirus vaccine shot developed by the National Institutes of Health and Moderna Inc., July 2020. Hans Pennink/AP Hans Pennink/AP Data on Moderna's Covid-19 vaccine in young children won't be available until 2022, CEO says at JPMorgan Healthcare conference. The study will take longer because they have to start at a much lower dose. Studies have already begun in children ages 12 and up. Visit Business Insider's homepage for more stories. Moderna will begin studying the...
Tags: News, Trends, Healthcare, Food And Drug Administration, Pfizer, Vaccine, Disneyland Resort, Centers For Disease Control And Prevention, Jpmorgan, Moderna, JPMorgan Healthcare, Stéphane Bancel, Hans Pennink, Coronavirus, Bancel, COVID-19


Coronavirus vaccines don't contain microchips. Here's what's actually in the shots.

A nurse prepares a coronavirus vaccine shot developed by the National Institutes of Health and Moderna Inc., July 2020. Hans Pennink/AP The coronavirus vaccine does not contain a microchip, contrary to a widely-shared conspiracy theory. The false claim that says Bill Gates is plotting to use the vaccine to track people via microchip may have come from a Facebook video containing altered and out-of-context interviews. The vaccine actually contains a tiny piece of genetic material encased in...
Tags: Facebook, Usa, Science, Microsoft, Trends, Bill Gates, Fda, Pfizer, Vaccine, Conspiracy Theories, Anthony Fauci, Microchip, Gates, Reuters, CBN, Moderna


Here are the common side effects you should expect if you get Moderna's coronavirus shot

A nurse prepares a coronavirus vaccine shot developed by the National Institutes of Health and Moderna Inc., July 2020. Hans Pennink/AP More than nine in 10 people immunized with Moderna's coronavirus vaccine candidate registered some level of side effects.  These side effects were predominantly expected for any vaccine, mild or moderate in intensity, and lasted for one to three days, according to briefing documents released Tuesday by the US Food and Drug Administration.  The FDA is now r...
Tags: Health, Science, US, Trends, New York Times, Healthcare, Fda, Pfizer, Vaccine, Biotech, Polaroid, Bell, US Food and Drug Administration, Moderna, Andrew Dunn, Hans Pennink


The FDA will likely grant Moderna's COVID-19 vaccine emergency use authorization on Friday

A nurse prepares a coronavirus vaccine shot developed by the National Institutes of Health and Moderna Inc., July 2020. Hans Pennink/AP The US Food and Drug Administration will approve the Moderna vaccine on Friday, The New York Times reported. FDA regulators confirmed Moderna's vaccine was 94.1% effective at preventing COVID-19 in late-stage trials, per agency documents released Tuesday. The US bought 200 million doses of Moderna's vaccine as of December 15. Moderna CEO Stéphane Bancel pr...
Tags: Politics, Science, News, White House, US, Trends, New York Times, Healthcare, Oxford, Astrazeneca, Fda, Pfizer, Vaccine, Oxford University, Times, Johnson Johnson


One chart shows how effective Moderna's vaccine is at preventing people from getting COVID-19

Nurse Kath Olmstead, right, gives volunteer Melissa Harting an injection as part of a COVID-19 vaccine trial, developed by the National Institutes of Health and Moderna Inc., on July 27, 2020. Hans Pennink/AP The Food and Drug Administration released data about Moderna's coronavirus vaccine on Tuesday. The FDA data suggests the company's two-shot course works very well to prevent COVID-19 infections. If authorized by the FDA, Moderna's shot would become the US's second coronavirus vaccine....
Tags: Science, US, America, Trends, Public Health, Healthcare, Food And Drug Administration, Fda, Pfizer, US Food and Drug Administration, New York Times Read, EUA, Moderna, Hans Pennink, Hilary Brueck, Coronavirus


3 coronavirus vaccines so far seem to prevent COVID-19. Here's how their efficacy compares to vaccines for flu, measles, and more.

A healthcare worker injects a patient with the Pfizer and BioNTech coronavirus vaccine during the phase 3 trial in Turkey in October. Dogukan Keskinkilic/Anadolu Agency via Getty Images AstraZeneca reported last week that its coronavirus vaccine candidate was 70% effective, on average, in preventing COVID-19 in clinical trials. Moderna and Pfizer's vaccine candidates were found to be 94% and 95% effective, respectively.  The chart below shows how the efficacy of those vaccine candidates co...
Tags: Health, UK, Science, News, Massachusetts, Trends, Turkey, MMR, Food And Drug Administration, Brazil, Astrazeneca, Fda, Pfizer, University of Oxford, Pascal Soriot, Johnson Johnson


Moderna and Pfizer's coronavirus vaccines are more than 94% effective. Here's how that compares to shots for flu, measles, and more.

A healthcare worker injects a patient with the Pfizer and BioNTech coronavirus vaccine during the phase 3 trial in Turkey in October. Dogukan Keskinkilic/Anadolu Agency via Getty Images Pfizer reported Wednesday that its coronavirus vaccine candidate was found to be 95% effective in preventing COVID-19 in clinical trials. Moderna's vaccine candidate was found to be 94.5% effective in trials. The chart below shows how the efficacy of those vaccine candidates compares to the effectiveness of...
Tags: Health, Science, News, Nbc, Massachusetts, Trends, Turkey, MMR, Food And Drug Administration, Astrazeneca, Pfizer, Anthony Fauci, Johnson Johnson, Moderna, Andrew Dunn, BioNtech


Moderna's coronavirus vaccine can cause severe fatigue and aches and pains. Two top vaccine experts told us why they think you'll still take it.

Moderna COVID vaccine trial volunteer receives injection that could be the vaccine. Data's been released that provides an indication of possible side effects. Hans Pennink/AP Photo Moderna said its vaccine has side effects like muscle aches and fatigue. Experts say that if the vaccine prevents COVID-19, then mild or moderate side effects won't impact vaccine uptake. The experts said they're waiting on the full data before recommending Moderna's shot.  Visit Business Insider's homepage ...
Tags: Trends, Joe Biden, Philadelphia, Fda, GlaxoSmithKline, Pfizer, US Food and Drug Administration, GSK, Fitzpatrick, Children s Hospital, Goodman, Emergency Department, Paul Offit, Lisa Fitzpatrick, Moderna, Offit


Moderna and Pfizer's coronavirus vaccines are more than 90% effective. Here's how that compares to shots for the flu, measles, and more.

A healthcare worker injects a patient with the Pfizer and BioNTech coronavirus vaccine during the phase 3 trial in Turkey in October. Dogukan Keskinkilic/Anadolu Agency via Getty Images Moderna announced Monday that its coronavirus vaccine candidate was found to be 94.5% effective in preventing COVID-19 in clinical trials. Pfizer announced last week that its coronavirus vaccine candidate was found to be more than 90% effective. The chart below shows how those vaccine candidates' efficacy c...
Tags: Health, Science, News, Nbc, Massachusetts, Trends, Turkey, MMR, Food And Drug Administration, Astrazeneca, Fda, Pfizer, Vaccines, Anthony Fauci, Johnson Johnson, Moderna


Moderna's coronavirus vaccine requires 2 shots given a month apart, which makes it tougher to get everyone fully inoculated

A nurse prepares a coronavirus vaccine developed by Moderna and the National Institutes of Health, July 2020. Hans Pennink/AP Moderna announced Monday that its coronavirus vaccine candidate was found to be 94.5% effective in preventing COVID-19 in clinical trials. The vaccine requires two shots administered four weeks apart, which could make distribution more complicated. People may need additional booster shots later, experts say. Visit Business Insider's homepage for more stories. Two co...
Tags: Health, Science, News, Massachusetts, Trends, Turkey, Astrazeneca, National Institutes of Health, Pfizer, Anthony Fauci, Mount Sinai, Boston Globe, Johnson Johnson, Icahn School of Medicine, Cambridge Massachusetts, NBC s Today


It's probably time to reset your expectations about when we'll get a COVID-19 vaccine. The timeline was always aspirational.

Nurse Kath Olmstead gives volunteer Melissa Harting an injection as part of a COVID-19 vaccine trial, developed by the National Institutes of Health and Moderna, on July 27, 2020. Hans Pennink/AP The estimated timelines for when we might see a coronavirus vaccine are slipping.  Anthony Fauci recently said it "could be January, could be later," before the FDA green-lights a coronavirus vaccine. Johnson and Johnson and AstraZeneca have both had to temporarily delay their clinical trials, whi...
Tags: Health, Science, News, Washington Post, New York City, US, Trends, South Africa, Arizona, Food And Drug Administration, Astrazeneca, National Institutes of Health, Fda, Pfizer, Pascal Soriot, Johnson


Health secretary Alex Azar says all Americans who want a vaccine could get one by spring 2021

Alex Azar, Health and Human Services Secretary, speaks to reporters in Washington on February 28, 2020. Reuters The US is on track to start delivering coronavirus shots before the end of 2020, Health and Human Services Secretary Alex Azar said on Wednesday. Azar said the country should have enough doses for seniors, healthcare workers, and first responders by the end of January — and for all Americans who want a shot by early April. But that timeline hinges on the success of at least one v...
Tags: Science, News, Cdc, Washington, US, Trends, Cnn, United States, Fda, Pfizer, Anthony Fauci, Centers For Disease Control And Prevention, Reuters, Butler, HHS, Department of Health and Human Services


6 vaccine experts told us how they'll decide whether to get a coronavirus shot

Getty Business Insider asked six infectious-disease experts when they'd feel confident getting a coronavirus vaccine.  Their answers varied in terms of which data would convince them.  Richard Condit, a retired University of Florida virologist, said he'd trust the scientists making the critical regulatory decision. Ultimately, if they recommended people his age get the shot, he'd likely get it, he said.  Other experts wanted more. University of Pennsylvania's Dr. Paul Offit emphasized the...
Tags: Science, US, Trends, Public Health, Harvard, Healthcare, Food And Drug Administration, National Institutes of Health, Philadelphia, Fda, University of Pennsylvania, University of Florida, GlaxoSmithKline, Pfizer, Vaccine, Bill


Drug companies are recruiting Black Americans to participate in COVID-19 vaccine trials, trying to break down decades of mistrust

A volunteer receives an injection from a medical worker. Siphiwe Sibeko/Pool via AP Black Americans have been affected by the coronavirus at a disproportionate rate, but many have been wary to participate in vaccine trials. The mistrust, experts told Insider, stems from decades of medical experimentation on Black Americans. At least two pharmaceutical companies developing vaccines — Moderna and Pfizer — have been trying to recruit more Black participants in their trials. Some HBCUs, includ...
Tags: Science, News, Cdc, Stanford, US, Trends, Georgia, Cnn, Racism, Trials, Pfizer, Donald Trump, Anthony Fauci, Business Insider, Trump, University of Wisconsin Madison


5 vaccine experts told us what they'd need to know before they'd feel comfortable taking a coronavirus shot

Getty Business Insider asked five infectious-disease experts when they'd feel confident getting a coronavirus vaccine.  Their answers varied in terms of what data would convince them.  Richard Condit, a retired University of Florida virologist, said he'd trust the scientists making the critical regulatory decision. Ultimately, if they recommend people his age get the shot, he'd likely get it, he said.  Other experts wanted more. University of Pennsylvania's Dr. Paul Offit emphasized the n...
Tags: Science, US, Trends, Public Health, Harvard, Healthcare, Food And Drug Administration, Philadelphia, Fda, University of Pennsylvania, University of Florida, GlaxoSmithKline, Vaccine, Bill, Centers For Disease Control And Prevention, Trump


156 countries joined a major, WHO-led effort to develop and distribute coronavirus vaccines. The US and China aren't among them.

U.S. President Donald Trump speaks during his first re-election campaign rally in several months in the midst of the coronavirus disease (COVID-19) outbreak in Tulsa, Oklahoma, U.S., June 20, 2020. REUTERS/Leah Millis So far, 156 countries have signed on to Covax, a WHO-backed effort to develop and distribute coronavirus vaccines. The Trump administration has said the US won't participate, however, and China is also opting out.   Health experts are concerned that the US's absence from Cova...
Tags: Australia, Saudi Arabia, China, US, Trends, Who, World Health Organization, Fujifilm, Pfizer, University Of Queensland, Vox, Donald Trump, Nih, The Washington Post, Clover, Trump


Dr. Fauci hasn't figured out what he's doing for the holidays yet

Welcome to Business Insider's daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday. Hollis Johnson/Business Insider Hello,Boy, what a week it's been. I don't know about you, but much of my waking time is spent thinking about the vaccine trials that are underway, what results we might get, and when life might start to feel fully "normal."We'll get into everything we've learned about the vacc...
Tags: Apple, Spacex, UK, New York, Cdc, Senate, US, Trends, Astrazeneca, Roy, Pfizer, Morgan Stanley, Anthony Fauci, Business Insider, Nyse, Reuters


The CDC director said most Americans wouldn't get a coronavirus vaccine until summer or fall 2021. Trump says Redfield was 'confused.'

Dr. Robert Redfield, the director of the Centers for Disease Control and Prevention, at a House subcommittee hearing on July 31 in Washington, DC. Erin Scott-Pool/Getty Images At a Senate subcommittee hearing on Wednesday, CDC Director Robert Redfield said most Americans probably wouldn't receive a coronavirus vaccine until "late second quarter, third quarter 2021."  Hours later, President Donald Trump said Redfield was "confused." "I think he made a mistake when he said that. It's just in...
Tags: Science, News, Cdc, Washington, Senate, US, Trends, House, Food And Drug Administration, Fda, Pfizer, Vaccine, Donald Trump, Anthony Fauci, Centers For Disease Control And Prevention, Trump


Don't expect a coronavirus vaccine before the election — here's the likely timeline according to doctors, government officials, and analysts

Nurse Kath Olmstead (right) gives volunteer Melissa Harting (left) the Moderna vaccine on July 27, 2020, in Binghamton, New York. AP Photo/Hans Pennink President Trump has suggested that a coronavirus vaccine may become available "right around" the election on November 3. But public-health experts, financial analysts, and US government officials have said that timeline is unrealistic. Most experts think there's little hope of a vaccine being ready before the end of the year. Under the most...
Tags: UK, Science, News, Cdc, Senate, White House, US, Trends, Food And Drug Administration, Astrazeneca, Cbs, National Institutes of Health, Philadelphia, Goldman Sachs, Fda, Npr


Trump won't join a WHO-organized coronavirus vaccine development effort. That could leave the US in the lurch if domestic candidates fail.

President Donald Trump speaks during a re-election campaign rally in Tulsa, Oklahoma, June 20, 2020. REUTERS/Leah Millis The Trump administration says the US won't participate in COVAX, an international, WHO-backed effort to develop and distribute coronavirus vaccines.  Trump has pledged to withdraw the US from the WHO entirely, calling the group's pandemic response "China-centric." Health experts are concerned that the US's absence from COVAX could impede the country's access to vaccines ...
Tags: Washington Post, White House, China, US, Trends, United States, United Nations, Who, World Health Organization, Astrazeneca, Fda, Fujifilm, Pfizer, Donald Trump, Nih, Trump


The most powerful people influencing Trump on healthcare

A doctor holds a swab for coronavirus testing. Britta Pedersen/picture alliance via Getty Images Hello,Welcome to Dispensed, Business Insider's healthcare newsletter. I'm Kimberly Leonard, and I'm BI's healthcare reporter focused on policy and politics.I'm guest hosting our newsletter today from Philadelphia. Thanks to a quick turnaround in coronavirus testing provided for free in Washington, DC, I was able to get cleared before visiting family here. It's a huge relief to have that peace of...
Tags: Google, Politics, Ipo, Trends, Walmart, Washington Dc, Testing, Healthcare, Health policy, Philadelphia, Vaccine, Donald Trump, Trump, Mike Pence, Centers for Medicare, Medicaid Services


Moderna's latest coronavirus vaccine results

Hollis Johnson/Business Insider Hello,Here's the healthcare news you need to know: There's more promising data on Moderna's coronavirus vaccine, the White House approved new coronavirus testing guidelines without input from Dr. Anthony Fauci, and Google explains its $100 million bet on telehealth.I'm your host of today's Dispensed Daily, Blake Dodge, the healthcare team's health-tech reporter. I welcome tips about Big Tech's healthcare doings. You can reach me at [email protected]
Tags: Google, New York, Cdc, Washington, White House, Trends, Walmart, Tennessee, Fda, Anthony Fauci, Centers For Disease Control And Prevention, Mike Pence, Blake, Harpersville, Binghamton, Department of Health and Human Services


New York, New Jersey Investigating Sex Abuse And Cover-Ups By Clergy

The attorneys general for both states have launched active investigations into abuse allegations. Last month, a grand jury report from Pennsylvania detailed abuse by more than 300 Catholic priests.(Image credit: Hans Pennink and Julio Cortez/AP)
Tags: News, Pennsylvania, Catholic, New York New Jersey, Hans Pennink